XLRN | Acceleron Pharma Inc.

Healthcare sector

• Summary
• Earnings Call
• Events
• Charts
• Historical Data
• Dividends
• Upgrades
• Profile

Category: Consumer goods

• Industry: Biotechnology

Quick infos

• Headquarters:   Massachusetts, United States

Trade prices

• Volume:
• Market Cap:
• Prev closed:
• Open:
• High:
• Low:
• 52 week low:
• 52 week high:
• Dividends:

Top Stories (XLRN)

Earnings History

Date	EPS / Forecast	Revenue / Forecast
March 2, 2022
November 4, 2021	-1.16 / -0.9874	34.2M / 35.08M
August 5, 2021	-1.05 / -0.8683	27.94M / 30.92M
May 6, 2021	-1.05 / -0.7839	24.76M / 22.4M	Beat!
February 25, 2021	-0.95 / -0.5853	25.87M / 32.31M
view more

Historical Data

Date		Price		Open	High	Low		Vol	Change	ER
Nov 4, 2021		173.73		172.83	174.35	172.83		376.35K	0.40%
Nov 3, 2021		173.03		172.68	173.26	172.60		659.34K	0.20%
Nov 2, 2021		172.68		173.88	173.89	172.50		924.16K	-0.68%
Nov 1, 2021		173.87		174.00	174.26	173.33		690.92K	-0.18%
Oct 29, 2021		174.18		173.91	174.74	173.26		710.27K	-0.03%
Oct 28, 2021		174.24		174.35	174.37	173.25		1.08M	0.25%
Oct 27, 2021		173.80		173.78	174.51	173.30		594.82K	0.01%
Oct 26, 2021		173.78		173.73	174.15	173.50		245.75K	0%
Oct 25, 2021		173.78		174.41	174.57	173.51		335.69K	-0.1%
Oct 22, 2021		173.95		174.23	174.42	173.50		196.87K	0.12%
view more

Show all

News

News for (XLRN)

• Acceleron Pharma, Inc. to Host Earnings Call
  finance.yahoo.com Mar 23, 2021 4:15 pm
• Acceleron Pharma, Inc. to Host Earnings Call
  finance.yahoo.com Mar 23, 2021 2:45 pm
• 5 Biotech Stocks That More Than Doubled This Year
  finance.yahoo.com Mar 23, 2021 8:58 am
• Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living With Myelodysplastic Syndromes
  finance.yahoo.com Mar 23, 2021 7:37 am
• Acceleron Announces Third Quarter 2020 REBLOZYL® Net Sales
  finance.yahoo.com Mar 23, 2021 7:15 am
• Acceleron Pharma Inc (XLRN) Q3 2020 Earnings Call Transcript
  fool.com Mar 23, 2021 1:31 am
• Acceleron (XLRN) Stock Jumps 3.3%: Will It Continue to Soar?
  finance.yahoo.com Mar 22, 2021 11:12 am
• 15 Fastest Growing Biotech Companies in the US
  finance.yahoo.com Feb 27, 2021 9:23 am
• Recap: Acceleron Pharma Q4 Earnings
  finance.yahoo.com Feb 25, 2021 5:00 pm
• Acceleron to Webcast Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
  finance.yahoo.com Feb 17, 2021 7:00 am
• Acceleron Announces Fourth Quarter and Full Year 2020 REBLOZYL® Net Sales
  finance.yahoo.com Feb 4, 2021 7:10 am
• Is XLRN A Good Stock To Buy According To Hedge Funds?
  finance.yahoo.com Dec 22, 2020 4:30 pm
• Acceleron's (XLRN) PAH Candidate Gets Orphan Designation in EU
  finance.yahoo.com Dec 15, 2020 9:22 am
• Were Hedge Funds Right About Embracing Acceleron Pharma Inc (XLRN)?
  finance.yahoo.com Oct 26, 2020 4:02 pm
• The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac
  finance.yahoo.com Sep 30, 2020 7:45 am
• Acceleron to Host Webcast Outlining the Design of Its Registrational Phase 3 STELLAR Trial of Sotatercept in Pulmonary Arterial Hypertension (PAH) on October 2, 2020
  finance.yahoo.com Sep 17, 2020 4:01 pm
• Companies Like Acceleron Pharma (NASDAQ:XLRN) Are In A Position To Invest In Growth
  finance.yahoo.com Sep 13, 2020 10:55 am
• 
  Acceleron Pharma stock soars more than 50% on hypertension drug study
  marketwatch.com Aug 13, 2020 4:22 pm
• 
  Acceleron Soars in After-Hours Trading on Positive Trial Results for Hypertension Treatment
  thestreet.com Aug 13, 2020 12:37 pm
• Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
  finance.yahoo.com Jan 4, 2021 7:00 am

Key Persons

Talk about Acceleron Pharma Inc. below in comments section below.

Do you think you'll buy? Do you already have active trades now?

EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.

Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.